Search
for
Sort by
Research 631–660 of 1000+
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Hormone Blocking Anticancer Drugs
- Hiperandrogenismo tras la menopausia
- Free Papers Medical and Surgical: Hair and Nails
- Decades of progressive red and yellow nodules
- Generalised Gingival Fibromatosis and Hypertrichosis: A Rare Case of Syndromic Presentation
- Skin Diseases in Horses
- Role of the Wnt signaling pathway in keratoacanthoma
- Atlas of Geriatric Dermatology
- Eccrine angiomatous hamartoma
- An Interesting Case of Hepatic Adrenocortical Carcinoma.
- A case of androgen-secreting adrenal carcinoma with non-classical congenital adrenal hyperplasia
- Pediculosis
- Hormesis and medicine
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- TGFβ and cancer metastasis: an inflammation link
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Clinical applications of antiandrogens
- Hirsutism: diagnosis and treatment
- Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Cases Report the Cronkhite-Canada Syndrome
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica
- Clinical Pearls in Men's Health
- What is your diagnosis? Fine‐needle aspirate from a subcutaneous preputial mass in a ferret
- 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia
- Slow progress in prostate cancer
- Condylomata acuminata of HIV-positive men may harbour focal areas of dysplasia: relevant implications for the management of human papillomavirus-induced disease in high-risk patients